Published in J Exp Med on December 01, 1991
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med (1996) 3.36
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. J Exp Med (1994) 2.61
Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52
Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A (1996) 2.02
CD8 T cell memory in B cell-deficient mice. J Exp Med (1996) 1.97
B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J Exp Med (1993) 1.84
CD4+ T cell activation and tolerance induction in B cell knockout mice. J Exp Med (1996) 1.32
Allergic airway sensitization induces T cell activation but not airway hyperresponsiveness in B cell-deficient mice. Proc Natl Acad Sci U S A (1997) 1.25
B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect Immun (1994) 1.21
Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect Immun (1999) 0.94
Comparison of antigen presentation by lymph node cells from protein and peptide-primed mice. Immunology (1993) 0.84
Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice. Transplantation (2011) 0.76
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med (1990) 5.35
The functions of the thymus system and the bursa system in the chicken. J Exp Med (1966) 4.07
T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol (1987) 2.93
The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J Immunol (1987) 2.55
Dendritic cells are the principal cells in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med (1990) 2.54
The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice. J Immunol (1988) 2.39
Can B cells turn on virgin T cells? Nature (1988) 2.34
Compartmentalization of MHC class II gene expression in transgenic mice. Cell (1988) 2.08
Lymphocytes in congenital immunological deficiency diseases. Clin Exp Immunol (1968) 1.87
T cell development in B cell-deficient mice. IV. The role of B cells as antigen-presenting cells in vivo. J Immunol (1986) 1.62
Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur J Immunol (1981) 1.49
The function of antigen-presenting cells in mice with severe combined immunodeficiency. J Immunol (1985) 1.36
Adoptive transfer of neonatal T lymphocytes rescues immunoglobulin production in mice with severe combined immune deficiency. J Exp Med (1991) 1.23
Mouse spleen dendritic cells present soluble antigens to antigen-specific T cell hybridomas. J Exp Med (1983) 1.05
Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol (1977) 1.03
Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry (1994) 1.84
International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69
Inhibition of angiogenesis by a mouse sprouty protein. J Biol Chem (2000) 1.54
The distribution of the fiber cell intrinsic membrane proteins MP20 and connexin46 in the bovine lens. J Cell Sci (1992) 1.26
Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem (1995) 1.24
Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J Biol Chem (1993) 1.02
Signaling through CD19 activates Vav/mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/phosphatidylinositol 3-kinase complex in human B cell precursors. J Biol Chem (1994) 1.01
Food portion weights in primary and secondary school lunches in England. J Hum Nutr Diet (2008) 0.95
Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J Neuropathol Exp Neurol (1997) 0.90
Use of bovine viral diarrhoea virus as an internal control for amplification of hepatitis C virus. Vox Sang (1999) 0.87
Biobanks of blood from donors and recipients of blood products. Vox Sang (2008) 0.86
Reduced hypercapnic vasoreactivity in moyamoya disease. Neurology (1988) 0.86
A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol (1996) 0.85
Neurophysiologic syndromes in stroke as predictors of outcome. Arch Phys Med Rehabil (1978) 0.83
HCV and non-Hodgkin lymphoma. Lancet (1996) 0.81
Community-level determinants of child growth in an Indonesian tea plantation. Eur J Clin Nutr (2000) 0.80
Screening blood donations for hepatitis C virus by polymerase chain reaction. Vox Sang (2000) 0.78
High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia. J Gastroenterol Hepatol (1998) 0.76
DNA ploidy in thin melanoma. Pathology (1988) 0.75
Function of CD48 and its regulation by Epstein-Barr virus. Biochem Soc Trans (1993) 0.75
The Joint Theatre Clinical Case Conference (JTCCC): clinical governance in action. J R Army Med Corps (2010) 0.75
First HIV 'window period' donation in a UK blood donor. Transfus Med (2005) 0.75
HTLV antibody screening using mini-pools. Transfus Med (2001) 0.75
Effects of self-instructive materials in learning selected motor skills. Res Q (1967) 0.75
Language therapy program assisted by volunteers. Times (1978) 0.75